Available Technologies

Results

Bortezomib Prodrugs

Exclusively Licensed Technology / Case number: #20771JQ
Jeremiah A. Johnson / Irene Ghobrial / Alexandre Detappe / Hung Nguyen / Yivan Jiang / Paiman Ghoroghchian
Technology Areas: Therapeutics
Impact Areas: Healthy Living

Molecular Design of Antibodies with Enhanced Stability

Non-Exclusively Licensed Technology / Case number: #13229J
Bernhardt Trout / Veysel Kayser / Vladimir Voynov / Bernhard Helk / Naresh Chennamsetty
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Single Injection Delivery Systems

Exclusively Licensed Technology / Case number: #16746JQ
Robert Langer / Kevin McHugh / James Norman / Stephany Tzeng / Thanh Nguyen / William Gates / Boris Nikolic / Phillip Eckhoff / Lowell Wood / Ana Jaklenec / No Inventor
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living

Synthetic Oncolytic LNP-Replicon RNA for Cancer Immunotherapy

Exclusively Licensed Technology / Case number: #21306HJQ
Darrell J Irvine / Noor Momin / Yingzhong Li / Yizhou Dong / Ron Weiss / Karl Dane Wittrup
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living

Light-gated Ion Channels with Fast Kinetics and High Sensitivity

Exclusively Licensed Technology / Case number: #16950TEJ
Gane Wong / Adam Cohen / Daniel Hochbaum / Yongku Cho / Nathan Klapoetke / Edward Stuart Boyden / Brian Chow
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Sensing & Imaging / Therapeutics
Impact Areas: Healthy Living

A Dual-Barreled Medical Injector

Exclusively Licensed Technology / Case number: #23529
Kripa K Varanasi / Vishnu Jayaprakash
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living

Compositions and Methods for Promoting Hemostasis and other Physiological Activities.

Exclusively Licensed Technology / Case number: #12061J
Gerald Schneider / Yu Xiang Liang / David Tay / Kwok-Fai So / Rutledge Ellis-Behnke
Technology Areas: Biomaterials & Bioelectronics / Therapeutics
Impact Areas: Healthy Living

Rational Design of Affinity Improvement of Dengue 4e11 Antibody

Exclusively Licensed Technology / Case number: #15783
Ram Sasisekharan / Kannan Tharakaraman / Luke Robinson
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Anti-Dengue Virus NS1 Protein Monoclonal Antibodies

Non-Exclusively Licensed Technology / Case number: #18262J
Lee Gehrke / Helena de Puig Guixe / Irene Bosch / Jose Gomez-Marquez / Kimberly Hamad-Schifferli
Technology Areas: Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Determinants of Human Receptor Specificity of Influenza A Virus H2N2 Hemagglutinin

Exclusively Licensed Technology / Case number: #14302
Rahul Raman / Xiaoying Koh / Karthik Viswanathan / Aarthi Chandrasekaran / Ram Sasisekharan
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

Microbial Engineering for the Production of Chemical and Pharmaceutical Products from Isoprenoid Pathway

Exclusively Licensed Technology, Tangible Property / Case number: #13905J
Gregory Stephanopoulos / Heng Phon Too / Parayil Ajikumar
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living

Method for Screening Libraries of Enzymes with Improved Catalytic Properties or Altered Substrate Specificity Using Microwells for the Spatial Separation of Cells Producing the Enzymes

Exclusively Licensed Technology / Case number: #12967WJ
Kerry Love / J. Christopher Love
Technology Areas: Biotechnology / Chemicals & Materials / Diagnostics / Therapeutics
Impact Areas: Healthy Living

Brushed Prodrugs and Uses Thereof

Exclusively Licensed Technology / Case number: #21834
Jeremiah A. Johnson / Hung Nguyen / Yivan Jiang
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living

Highly Potent Monofunctional Platinum (II) Anticancer Agents, cDACP (acriplatin) and cDPnCP (phenanthriplatin)

Non-Exclusively Licensed Technology / Case number: #14702
Stephen J Lippard / Ga Young Park
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Biomaterials for Enhanced Implant-Host Integration

Exclusively Licensed Technology / Case number: #22709HJQ
Christopher Chen / Michael Yang / Ritika Chaturvedi / Jan Baranski / Kelly Stevens / Sangeeta Bhatia
Technology Areas: Biomaterials & Bioelectronics / Biotechnology / Therapeutics

Novel RNA Modality for Translation in Eukaryotic Cells

Exclusively Licensed Technology / Case number: #19874Q
Daniel Anderson / Robert Wesselhoeft / Piotr Kowalski
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living

Body Fluid Resistant Tissue Glues

Exclusively Licensed Technology / Case number: #21933J
Xuanhe Zhao / Christoph Nabzdyk / Xinyu Mao / Hyunwoo Yuk
Technology Areas: Biomaterials & Bioelectronics / Therapeutics

Lipomer Nanoparticles for Highly Efficient SiRNA Delivery

Exclusively Licensed Technology / Case number: #14649
Robert Langer / James Dahlman / Avraham Schroeder / Christopher Levins / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living

SAR of Bromodomain Inhibitor/Linker for Modulation of Release Profile of BET-BRUSH Prodrugs

Exclusively Licensed Technology / Case number: #20376
Jeremiah A. Johnson / Farrukh Vohidov
Technology Areas: Therapeutics
Impact Areas: Healthy Living

Broad Neutralizing Antibodies to Groups 1 and 2 Influenza HA

Exclusively Licensed Technology / Case number: #15049
Ram Sasisekharan / Vidya Subramanian / Kannan Tharakaraman / Venkataramanan Soundararajan / Sasisekharan Raguram / Viswanathan Sasisekharan
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 312 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.